Cargando…
Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
Alzheimer’s disease (AD) is a neurodegenerative disease that causes memory loss, cognitive decline, and eventually dementia. The etiology of AD and its pathological mechanisms remain unclear due to its complex pathobiology. At the same time, the number of patients with AD is increasing worldwide. Ho...
Autor principal: | Tashima, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876001/ https://www.ncbi.nlm.nih.gov/pubmed/35214143 http://dx.doi.org/10.3390/pharmaceutics14020411 |
Ejemplares similares
-
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates
por: Tashima, Toshihiko
Publicado: (2022) -
Delivery of Orally Administered Digestible Antibodies Using Nanoparticles
por: Tashima, Toshihiko
Publicado: (2021) -
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
por: Holst, Mikkel Roland, et al.
Publicado: (2023) -
A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding
por: Sade, Hadassah, et al.
Publicado: (2014) -
Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays
por: Simonneau, Claire, et al.
Publicado: (2021)